Massimo TRIGGIANI | INTERNAL MEDICINE
Massimo TRIGGIANI INTERNAL MEDICINE
cod. 1060100039
INTERNAL MEDICINE
| 1060100039 | |
| DEPARTMENT OF MEDICINE, SURGERY AND DENTISTRY "SALERNITANA MEDICAL SCHOOL" | |
| EQF7 | |
| MEDICINE AND SURGERY | |
| 2024/2025 |
| OBBLIGATORIO | |
| YEAR OF COURSE 6 | |
| YEAR OF DIDACTIC SYSTEM 2016 | |
| AUTUMN SEMESTER |
| SSD | CFU | HOURS | ACTIVITY | ||
|---|---|---|---|---|---|
| MEDICINA INTERNA - MOD 1 MEDICINA INTERNA | |||||
| MED/09 | 7 | 84 | LESSONS | ||
| MEDICINA INTERNA - MOD 2 MEDICINA INTERNA | |||||
| MED/09 | 1 | 12 | LESSONS | ||
| MEDICINA INTERNA - MOD 3 MEDICINA INTERNA | |||||
| MED/09 | 1 | 12 | LESSONS | ||
| Objectives | |
|---|---|
| THIS COURSE, STRUCTERED IN LESSONS, INTERACTIVE SESSIONS, PRACTICAL INTERACTIONS AND CASE DISCUSSION, HA STHE OBJECTIVE TO PROVIDE APPROPRIATE KNOWLEDGE TO ALLOW A CORRECT IDENTIFICATION, DIFFERENTIAL DIAGNOSIS AND FULL CLINICAL EVALUATION OF THE MAIN METABOLIC, DEGENERATIVE AND INFLAMMATORY DISEASES IN THE FIELD OF INTERNAL MEDICINE. THE INTEGRATED COURSE OF PHARMACOLOGY WILL GIVE FUNDAMENTAL TOOLS TO IMPLEMENT THE BEST PHARMACOLOGICAL APPROACH USED TO PREVENT AND TREAT THESE DISEASES AND TO MANAGE COMPLICATIONS OCCURRING DURING THE CLINICAL COURSE. |
| Prerequisites | |
|---|---|
| CLINICAL METHODOLOGY MEDICINE AND SURGERY; GENERAL PATHOLOGY AND PHYSIOPATHOLOGY MEDICAL PHARMACOLOGY AND TOXICOLOGY |
| Contents | |
|---|---|
| INTERNAL MEDICINE HYPERTENSION SECONDARY HYPERTENSION HEART FAILURE DIABETES HYPERLIPEMIAS PULMONARY EMBOLISM ATHEROSCLEROSIS HYPERURICEMIA AND GOUT CHRONIC DIARRHEA GLOMERULONEPHRITIS AND HEMATURIA ANEMIE THROMBOCYTOPENIA THROMBOTIC MICROANGIOPATHIES EDEMA AND ANGIOEDEMA PURPURA NEUROPATHIES IN INTERNAL MEDICINE PRURITUS IN INTERNAL MEDICINE HYPEREOSINOPHILIA FEVER OF UNKNOWN ORIGIN (FUO) AUTOINFLAMMATORY SYNDROMES SARCOIDOSIS PRIMARY AND SECONDARY LYMPHEDEMA SIEROSITIS PHARMACOLOGY ANTIHYPERTENSIVE DRUGS DIURETICS CENTRALLY ACTING SYMPATHOLYTIC DRUGS ADRENERGIC RECEPTOR ANTAGONISTS (BETA-BLOCKERS, ALPHA-BLOCKERS) VASODILATORS CALCIUM CHANNEL BLOCKERS AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM PHARMACOLOGICAL TREATMENT OF ISCHAEMIC HEART DISEASE ANTIANGINAL AGENTS DRUGS IN THE ACUTE CORONARY SYNDROME TREATMENT DRUGS FOR THE TREATMENT OF PERIPHERAL VASCULOPATHIES AND CLAUDICATIO INTERMITTENS. PHARMACOLOGICAL TREATMENT OF HEART FAILURE INOTROPIC AGENTS PHARMACOLOGICAL TREATMENT OF ACUTE HEART FAILURE PHARMACOLOGICAL TREATMENT OF CHRONIC HEART FAILURE ANTIARRHYTHMIC DRUGS ANTITHROMBOTIC DRUGS ANTIPLATELET DRUGS ORAL ANTICOAGULANTS PARENTERAL ANTICOAGULANTS THROMBOLYTIC DRUGS PHARMACOLOGICAL TREATMENT OF DYSLIPIDEMIA STATINS FIBRATES BILE ACID SEQUESTRANTS PCSK9 INHIBITORS ANTI-DIABETIC DRUGS INSULIN ORAL HYPOGLYCEMIC AGENTS PHARMACOLOGICAL TREATMENT OF GOUT ANTI-HYPERURICEMIC DRUGS TREATMENT OF ACUTE ATTACKS OF GOUT |
| Teaching Methods | |
|---|---|
| FRONTAL LESSONS, LECTURES; EDUCATION SEMINARS; DISCUSSION OF CLINICAL CASES |
| Verification of learning | |
|---|---|
| EXAM WITH EACH COURSE LECTURER OF THE INTEGRATED COURSE. THE EXAM GRADE IS EXPRESSED IN THIRTIETHS. COLLEGIAL EVALUATION OF THE MEMBERS OF THE EXAM COMMISSION. |
| Texts | |
|---|---|
| RUGARLI C. MEDICINA INTERNA SISTEMATICA. VIII EDIZIONE, PICCIN EDITORE, 2022. MANSOOR AM. MEDICINA INTERNA: DALLA CLINICA ALLA DIAGNOSI. PICCIN EDITORE, 2022 GOODMAN & GILMAN’S - LE BASI FARMACOLOGICHE DELLA TERAPIA – XIII EDIZIONE, A CURA DI LAURENCE L. BRUNTON, RANDA HILAL-DANDAN, BJÖRN C. KNOLLMANN – ZANICHELLI 2019; FARMACOLOGIA - PRINCIPI DI BASE E APPLICAZIONI TERAPEUTICHE – IV EDIZIONE, A CURA DI F. ROSSI, V. CUOMO, C. RICCARDI, AAVV - MINERVA MEDICA 2019; TRATTATO DI FARMACOLOGIA – II EDIZIONE, A CURA DI L. ANNUNZIATO, G. DI RIENZO – IDELSON-GNOCCHI 2016. |
| More Information | |
|---|---|
| PARTICIPATION TO COURSE IS MANDATORY |
BETA VERSION Data source ESSE3 [Ultima Sincronizzazione: 2024-11-18]
